TEVA PHARMACEUTICAL INDUSTRIES LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$42.09
+1.50%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+7.1%
3 months
+22.1%
6 months
+20.4%
1 year
+110.1%
Year to date
+34.9%
52-week range
$20.03 – $42.09
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$49.05B
P/E
69.5
P/B
6.3
P/S
2.8
Revenue
$17.32B
Net income
$706M
Diluted EPS
0.6
Gross margin
52.50%
Net margin
4.10%
Return on equity
9.10%
Total debt
$16.87B
Cash
$3.66B
Free cash flow
$1.35B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $4.14B | -$576M | 52.00% | -13.90% | $307M |
| Mar 31, 2026 | $3.98B | $369M | 49.50% | 9.30% | -$208M |
| Dec 31, 2025 | $4.71B | $480M | 56.40% | 10.20% | $1.02B |
| Sep 30, 2025 | $4.48B | $433M | 51.40% | 9.70% | $233M |
| Jun 30, 2025 | $4.18B | $282M | 50.30% | 6.80% | $131M |
| Mar 31, 2025 | $3.89B | $214M | 48.20% | 5.50% | -$232M |
| Dec 31, 2024 | $4.23B | -$217M | 50.10% | -5.10% | $446M |
| Sep 30, 2024 | $4.33B | -$437M | 49.60% | -10.10% | $545M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent TEVA news
All market newsNo ticker-linked stories are in the current archive.